Biopharma investment fund for sale
- Investment amount: >20m EUR
- Location: Worldwide
- Reason for sale: The owners of this pharma investment fund decided to raise capital or to sell its biotech fund
- #CFIE PHS014
Overview of this biopharma investment fund for sale
The owners of a licensing and development company with a form of a hybrid investment fund are looking or a buyer or for an investor. The fund is managed by an experienced team with long experience in pharma. Contact us to know more about this fund looking for investment.
Profile of this biopharma investment fund for sale
This company looking for an investor is a company, specialized in in-licensing early-stage biopharmaceutical assets, progressing them to their next value-creation point and out-license to industry partners. The company has a practical form of an investment fund, although officially it is a limited company.
The fund capital reaches 100M EUR, with participation from investors from 3M EUR. The fund is successful, its current stage at preclinical development complete. The fund has 20+ investors currently. The company Invests in early-stage assets, not companies. The main criteria for investing are
- Control of clinical development
- Reduced development overhead costs
- Avoid high late-stage development costs
The company actively manages its assets, by a project management team. The fund promises that the investor’s equity will be fully returned in year five of the project, with the Internal Rate of Return (IRR) of the cash flows reaching more than 50%.
If interested, we can send a presentation of the fund, in which more detailed information is included upon signing an NDA with CFIE.
Contact us to get details about this biopharma investment fund for sale
Activities of this biopharma investment fund for sale
The investment criteria of the fund are:
- Quality of science
- Licensing feasibility
- Patent Assessment
- Preclinical development completed
- Commercialization/Regulatory path
- Fit with the existing portfolio
- Risk/Return to value inflexion
- Business case
The identified opportunities, in which the fund managers are considering investment, include
- FSHD Muscular Dystrophy
- Alzheimer disease
- Depressive disorder
- Etc.
At some of the opportunities, the fund managers are already conducting a Due Diligence.
The company holds many partnerships with clinical organizations; currently, it has an Ongoing Clinical Trial Service Agreement with a CRO company in order to downstream clinical development at a reduced cost.
This fund can be a good opportunity to a major pharma player, who wants to get access to CRO organizations and good opportunities. More investors will be invited to the process to invest, therefore the investor can invest also a lower amount than 20M.
Highlights of this biopharma investment fund for sale
- The company for sale is a limited company working as a fund, currently in funding phase
- The fund is identifying opportunities in the pharma sector and investing according to its criteria
- The fund has a unique investment model with large ROI without a 20-year commitment and easy exit
More information on this biopharma investment fund for sale
Please get in touch if you are interested in learning more about this biopharma investment fund for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.